Analysis of protein drugs aggregation Using Size Exclusion Chromatography

Ultra High Performance Liquid Chromatograph Application News Nexera™ XS inert Analyses of Antibody Drugs Using Ultra High Performance Liquid Chromatography D. Fujimura, E. Ando, C. Oya, R. Suzuki User Benefits  Highly reproducible data can be acquired by suppressing the…

Application News LabSolutions™ MD: Software for Efficient Method Development based on Analytical Quality by Design Efficient Method Development of Monoclonal Antibody Size Variants by Size Exclusion Chromatography Shinichi Fujisaki and Chihiro Hosoi User Benefits  The separation between monoclonal antibody…

C190-E281 Technical Report Method Optimization for the Analysis of Monoclonal Antibodies by Size-Exclusion Chromatography Emiko Ando1, Daiki Fujimura1, Keiko Matsumoto1 A b s tra c t: Antibody drugs using monoclonal antibodies pose concerns over aggregates formed during production and storage…

Application News Biopharma / Nexera Bio UHPLC / Shim-pack Bio Diol Optimizing Aggregates Analysis – Mobile Phase No. AD-0226 ❑ Introduction Protein-based therapeutic products such as monoclonal antibodies (mAbs) have shown to be effective against a variety of diseases. However,…